In our previous article, we explored the AI Act and its impact on the clinical trials industry in Europe. This time, we would like to move from the regulatory outlook to practice and take a closer look at how artificial intelligence is already reshaping research today. From the discovery of novel molecules such as rentosertib, designed entirely with...
Artificial Intelligence is rapidly transforming clinical trials, offering opportunities to improve patient recruitment, trial efficiency, and data analysis. The European Union has taken a significant step to regulate this technology by introducing the AI Act, the world’s first comprehensive legal framework for AI. We are now one year into its...
Last Monday our team: Jarosław Kasprowicz, PhD, MBA, Monika Mastrzykowska and Marta Rzeszotarska had a great pleasure to participate in the opening of PolTREG S.A. own state-of-the art cell and gene therapy manufacturing facility, which is one of the most modern plants in Europe. CONGRATULATIONS! CLINMARK – CONTRACT...
Yesterday our team (Joanna Ruelland and Kaja Sieracka) participated in first in Poland Clinical Trails for Medical Device Conference in Warsaw. We are happy to share our expiriences and to help MD Companies with their projects. Our experts in Regulatory Department, Clinical Operations Department and Pharmacovigilance Department can help...